Disclosure of Securities Transactions
Disclosure of securities transactions by members of the Supervisory Board and Board of Management
To comply with Section 15 a of the German Securities Trading Act, members of the Board of Management and Supervisory Board and their close relatives are required to disclose all transactions involving the purchase or sale of Bayer stock where such transactions total EUR 5,000 or more in a calendar year.
According to information filed with the company by members of the Board of Management and Supervisory Board, their total holdings of Bayer stock and related financial instruments amounted to less than 1 percent of the issued stock on the closing date for the financial statements.
According to information filed with the company by members of the Board of Management and Supervisory Board, their total holdings of Bayer stock and related financial instruments amounted to less than 1 percent of the issued stock on the closing date for the financial statements.
Transactions in the current fiscal year
Date/ |
Name/ |
Security |
ISIN |
Type of |
Price/ |
Quantity |
Total |
May 13, |
Willy Beumann, |
Share |
DE0005752000 |
Buy |
EUR 55.72 |
261 |
EUR 14,542.92 |
Transactions in previous fiscal years
2007:
Date/ |
Name/ |
Security |
ISIN |
Type of |
Price/ |
Quantity |
Total |
March 29, |
Dr. Wolfgang Plischke, |
Share |
DE0005752000 |
Buy |
EUR 47.70 |
5,300 |
EUR 252,810.00 |
January 10, |
Dr. Wolfgang Plischke, Management Board |
PROTECT |
FI: |
Buy |
EUR 40.12 (Strike price: EUR 27.50 / Price multiplier: 1) |
350 | EUR 14,042.00 |
2006: No reportable securities transactions
2005: No reportable securities transactions
2005: No reportable securities transactions